Furthermore, 73.8% of cases with low miR‐378a‐3p expression (45/61 cases) in HCC tumor tissues showed a high level of PLAGL2, whereas only 24.1% of cases with high miR‐378a‐3p expression (7/29 cases) exhibited a high level of PLAGL2 (p < 0.01) (Figure 9M). The gene discussed is PLAGL2; the disease is hepatocellular carcinoma.